Cancer Moonshot℠ - Obligations by Budget Mechanism
With $300 million appropriated for Cancer Moonshot activities in fiscal year (FY) 2018, funding was allocated into four budget mechanisms: research grants, R&D contracts, intramural research, and research management and support, as shown in the chart below.
Similar to the institute’s annual appropriation, NCI reports Cancer Moonshot obligations by funding mechanism.
| Type of Mechanism | Mechanism | Number | Amount |
|---|---|---|---|
| Research Project Grants (RPGs) | Competing | 26 | $59,520,038 |
| Noncompeting | 20 | $22,300,821 | |
| Administrative Supplements | 31 | $4,421,709 | |
| Subtotal, without SBIR | 46 | $86,242,568 | |
| SBIR/STTR Grants | 7 | $4,367,647 | |
| Subtotal, RPGs | 53 | $90,610,215 | |
| Centers | Cancer Centers Grants-P30s | 0 | $10,954,951 |
| Cooperative Agreements-U54s/U41s | 11 | $61,079,470 | |
| Subtotal, Centers | 11 | $72,034,421 | |
| Other Research | Resource Grants-U24s/U2Cs | 15 | $93,173,756 |
| Subtotal, Other Research | 15 | $93,173,756 | |
| Subtotal, Research Grants | 79 | $255,818,392 | |
| Intramural Research | 0 | $4,034,821 | |
| Research Management & Support | 0 | $45,222 | |
| R&D Contracts | R&D Contracts | 7 | $38,802,916 |
| SBIR/STTR Contracts | 21 | $6,410,821 | |
| Subtotal, R&D Contracts | 28 | $45,213,737 | |
| Total | $305,112,172 | ||
| Includes FY 2017 Cures-Moonshot Carryover obligations. | |||